PopSugar: People With Eating Disorders Are Being Prescribed Ozempic — and the Results Are Dire
“The glucagon-like peptide 1, or GLP-1, drug is a fairly new medication that was originally approved by the Food and Drug Administration in 2017 for the treatment of type 2 diabetes. It was designed to improve blood sugar, along with diet and exercise, possibly leading to weight loss. But research has shown that nearly half…